Rankings
▼
Calendar
AXGN Q2 2024 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
Q2 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$48M
+25.6% YoY
Gross Profit
$35M
73.8% margin
Operating Income
-$428,000
-0.9% margin
Net Income
-$2M
-4.0% margin
EPS (Diluted)
$-0.04
QoQ Revenue Growth
+15.8%
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
$3M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$189M
Total Liabilities
$93M
Stockholders' Equity
$96M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$48M
$38M
+25.6%
Gross Profit
$35M
$30M
+19.2%
Operating Income
-$428,000
-$7M
+93.8%
Net Income
-$2M
-$7M
+71.2%
← FY 2024
All Quarters
Q3 2024 →